Medicure (MCUJF) Capital Leases (2016 - 2017)

Medicure's (MCUJF) quarterly Capital Leases came in at $2.4 million in Q3 2017, up 81.56% quarter-over-quarter from $1.3 million in Q2 2017.

Medicure (MCUJF) Capital Leases (2016 - 2017) Analysis & Trends

Medicure's Capital Leases history runs 2 years deep, the most recent figure standing at $2.4 million for Q3 2017.

On a quarterly basis, Capital Leases changed N/A year-over-year to $2.4 million in Q3 2017; TTM through Sep 2017 was $2.4 million, a N/A change from a year earlier, with the FY2017 full-year figure at $2.5 million, changed N/A from the prior year.
Capital Leases climbed to $2.4 million in Q3 2017 per MCUJF's latest filing, from $1.3 million in the prior quarter.
Across five years, Capital Leases topped out at $2.4 million in Q3 2017 and bottomed at $158336.8 in Q1 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn
10	Medicure	8.77 Mn	7.64 Mn	2.57 Mn

Download Data